Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory
MedTech
FDA clears Dexcom's basal dosing software for Type 2 diabetes
Dexcom said Smart Basal is the first CGM-integrated application in Type 2 diabetes for people taking a glargine U-100 long-acting insulin.
Conor Hale
Nov 19, 2025 9:45am
Fierce Pharma
George Tidmarsh exits as LinkedIn post sparks lawsuit, probe
Nov 3, 2025 11:13am
Medtronic clips EU approval for Penditure LAA implant
Oct 2, 2025 12:00pm
FDA clears Biolinq's color-coded sensor patch for glucose ranges
Sep 29, 2025 11:30am
FDA clears Microbot’s remote-controlled cath lab system
Sep 8, 2025 11:45am
Medtronic debuts Abbott Instinct CGM as MiniMed 780G enters T2D
Sep 2, 2025 11:00am
